About Us
Swiss Startup
MUGENBIO is a medtech startup based in Kanton Zurich, Switzerland.
Our mission is to break technological barriers in the way of medical diagnostics. We are developing novel biotechnologies, which will enable earlier and more accurate detection of male cancers.
Knowledge and Vision
Current molecular diagnostic of male cancers is seriously flawed. We need to develop more advanced methodology enabling earlier and more accurate detection of prostate cancer. At MUGENBIO, we have all the knowledge, expertise and vision perquisite to disrupt current diagnostics of cancers.
This is why, we are developing the next generation platform for prostate cancer diagnostic. With our high-resolution cancer screening technology, millions of lives will be saved.
Strategy and Future
Performance of novel technology often depends on totality of the advanced solutions integrated in the final product. Therefore, our diagnostic platform is developed according to the R&D strategy, which conceptually integrates three innovation pillars. We believe that our comprehensive approach, will lead to successful development of the most advanced diagnostic platform, which will democratise early and accurate prostate cancer detection.